TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/29/2026
Back to search
Official data from USPTO
NEUEXCELL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
06/30/2026
Trademark type
Word
Nice classes
42
Filing date
03/04/2024
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/31/2025
First use in commerce
03/31/2025
Drawing code
4
Owner type
03
Owner location
Philadelphia, PA, US
Examiner
GALLOWAY, JAMILLA ESPY
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NeuExcell Therapeutics Inc.
Representatives
Lawrence M. Green Merchant & Gould P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals for the treatment of Alzheimer's diseaseParkinson's diseaseamyotrophic lateral sclerosis (ALS)Huntington's diseaseepilepsyphysical injurystrokecerebral aneurysmtraumatic brain injuryconcussiona tumorcancerinflammationinfectionataxiabrain atrophyspinal cord atrophymultiple sclerosistraumatic spinal cord injuryischemic or hemorrhagic myelopathy (myelopathy)global ischemiahypoxic ischemic encephalopathyembolismfibrocartilage embolism myelopathythrombosisnephropathychronic inflammatory diseasemeningitiscerebral venous sinus thrombosisretinal disease and other disease arising from neuronal damage; and testinginspectionresearch or development of pharmaceutical preparations for gene therapy or small molecule treatment
Publications
History of USPTO decisions and trademark events.
21 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/29/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/29/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/29/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/29/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/02/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/25/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/25/2025
IUAF
USE AMENDMENT FILED
06/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
06/05/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2024
DOCK
ASSIGNED TO EXAMINER
09/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/15/2024
NWAP
NEW APPLICATION ENTERED
03/04/2024
Continuous trademark protection
Get notified about every new filing that threatens NEUEXCELL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.